Cytokine rescue of p53-dependent apoptosis and cell cycle arrest is mediated by distinct Jak kinase signaling pathways

Genes and Development

Volumn 12, Issue 8, 1998, Pages 1099-1107

  Quelle, Frederick W ^a,b   Wang, Jinling ^a   Feng, Jian ^a   Wang, Demin ^a   Cleveland, John L ^a,c   Ihle, James N ^a,c   Zambetti, Gerard P ^a  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^b UNIVERSITY OF IOWA   (United States)

^c UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

Author keywords

Bcl 2; Bcl x; Erythropoietin; Interleukin 3; Jak; p53

Indexed keywords

PROTEIN P53;

ANIMAL CELL; APOPTOSIS; ARTICLE; BONE MARROW CELL; CELL CYCLE; CELL CYCLE G2 PHASE; CELL SURVIVAL; CONTROLLED STUDY; DNA DAMAGE; HEMATOPOIETIC CELL; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

ANIMALIA;

EID: 0032522453     PISSN: 08909369     EISSN: None     Source Type: Journal    
DOI: 10.1101/gad.12.8.1099     Document Type: Article

References (35)

1. Ashmun, R.A., A.T. Look, W.M. Roberts, M.F. Roussel, S.T. Seremetis, M. Ohtsuka, and C.J. Sherr. 1989. Monoclonal antibodies to the human CSF-1 receptor (c-fms proto-oncogene product) detect epitopes on normal mononuclear phagocytes and on human myeloid leukemic blast cells. Blood 73: 827-837.
2. Bottaro, D.P., J.S. Rubin, D.L. Faletto, A.M. Chan, T.E. Kmiecik, G.F. Vande Woude, and S.A. Aaronson. 1991. Identification of the hepatocyte growth factor receptor as the c-met proto-oncogene product. Science 251: 802-804.
3. Canman, C.E., T.M. Gilmer, S.B. Coutts, and M.B. Kastan. 1995, Growth factor modulation of p53-mediated growth arrest versus apoptosis. Genes & Dev. 9: 600-611.
4. Cleveland, J.L., J. Troppmair, G. Packham, D.S. Askew, P. Lloyd, M. Gonzalez-Garcia, G. Nunez, J.N. Ihle, and U.R. Rapp. 1994. v-raf suppresses apoptosis and promotes growth of interleukin-3-dependent myeloid cells, Oncogene 9: 2217-2226.
5. Collins, M.K., J. Marvel, P. Malde, and A. Lopez-Rivas. 1992. Interleukin 3 protects murine bone marrow cells from apoptosis induced by DNA damaging agents. J. Exp. Med. 176: 1043-1051.
6. Damen, J.E., R.L. Cutler, H. Jiao, T. Yi, and G. Krystal. 1995. Phosphorylation of tyrosine 503 in the erythropoietin receptor (EpR) is essential for binding the P85 subunit of phosphatidylinositol (PI) 3-kinase and for EpR-associated PI 3-kinase activity. J. Biol. Chem. 270: 23402-23408.
7. el-Deiry, W.S., T. Tokino, V.E. Velculescu, D.B. Levy, R. Parsons, J.M. Trent, D. Lin, W.E. Mercer, K.W. Kinzler, and B. Vogelstein. 1993. WAF1, a potential mediator of p53 tumor suppression. Cell 75: 817-825.
8. Franke, T.F., D.R. Kaplan, and L.C. Cantley. 1997. PI3K: Downstream AKTion blocks apoptosis. Cell 88: 435-437.
9. Hartmann, G., K.M. Weidner, H. Schwarz, and W. Birchmeier. 1994. The motility signal of scatter factor/hepatocyte growth factor mediated through the receptor tyrosine kinase met requires intracellular action of Ras. J. Biol. Chem. 269: 21936-21939.
10. Hollstein, M., B. Shomer, M. Greenblatt, T. Soussi, E. Hovig, R. Montesano, and C.C. Harris. 1996. Somatic point mutations in the p53 gene of human tumors and cell lines: Updated compilation. Nucleic Acids Res. 24: 141-146.
11. Ihle, J.N. 1995. Cytokine receptor signalling. Nature 377: 591-594.
12. Ihle, J.N. and D. Askew. 1989. Origins and properties of hematopoietic growth factor-dependent cell lines. Int. J. Cell Cloning 7: 68-91.
13. Kastan, M.B., Q. Zhan, W.S. el-Deiry, F. Carrier, T. Jacks, W.V. Walsh, B.S. Plunkett, B. Vogelstein, and A.J. Fornace, Jr. 1992. A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia-telangiectasia. Cell 71: 587-597.
14. Klingmuller, U., U. Lorenz, L.C. Cantley, B.C. Neel, and H.F. Lodish. 1995. Specific recruitment of SH-PTP1 to the erytl ropoietin receptor causes inactivation of JAK2 and termina-tion of proliferative signals. Cell 80: 729-738.
15. Kuerbitz, S.J., B.S. Plunkett, W.V. Walsh, and M.B. Kastan. 1992. Wild-type p53 is a cell cycle checkpoint determinant following irradiation. Proc. Natl. Acad. Sci 89: 7491-7495.
16. Lin, Y. and S. Benchimol. 1995. Cytokines inhibit p53-mediated apoptosis but not p53-mediated G1 arrest. Mol. Cell. Biol. 15: 6045-6054.
17. Lowe, S.W., E.M. Schmitt, S.W. Smith, B.A. Osborne, and T. Jacks. 1993. p53 is required for radiation-induced apoptosis in mouse thymocytes. Nature 362: 847-849.
18. Miura, O., A. D'Andrea, D. Kabat, and J.N. Ihle. 1991. Induction of tyrosine phosphorylation by the erythropoietin receptor correlates with mitogenesis. Mol. Cell. Biol. 11: 4895-4902.
19. Miura, O., J.L. Cleveland, and J.N. Ihle. 1993. Inactivation of erythropoietin receptor function by point mutations in a region having homology with other cytokine receptors. Mol. Cell. Biol. 13: 1788-1795.
20. Miura, O., N. Nakamura, J.N. Ihle, and N. Aoki. 1994a. Erythropoietin-dependent association of phosphatidylinositol 3-kinase with tyrosine-phosphorylated erythropoietin receptor. J. Biol. Chem. 269: 614-620.
21. Miura, O., N. Nakamura, F.W. Quelle, B.A. Witthuhn, J.N. Ihle, and N. Aoki. 1994b. Erythropoietin induces association of the JAK2 protein tyrosine kinase with the erythropoietin receptor in vivo. Blood 84: 1501-1507.
22. Miura, Y., O. Miura, J.N. Ihle, and N. Aoki. 1994c. Activation of the mitogen-activated protein kinase pathway by the erythropoietin receptor. J. Biol. Chem. 269: 29962-29969.
23. Miyashita, T. and J.C. Reed. 1995. Tumor suppressor p53 is a direct transcriptional activator of the human bax gene. Cell 80: 293-299.
24. Mizuno, K., O. Higuchi, J.N. Ihle, and T. Nakamura. 1993. Hepatocyte growth factor stimulates growth of hematopoietic progenitor cells. Biochem. Biophys. Res. Comm. 194: 178-186.
25. Nakamura, Y., N. Komatsu, and H. Nakauchi. 1992. A truncated erythropoietin receptor that fails to prevent programmed cell death of erythroid cells. Science 257: 1138-1141.
26. Nakamura, N., H. Chin, N. Miyasaka, and O. Miura. 1996. An epidermal growth factor receptor/Jak2 tyrosine kinase domain chimera induces tyrosine phosphorylation of stat5 and transduces a growth signal in hematopoietic cells. J. Biol. Chem. 271: 19483-19488.
27. Nip, J., D.K. Strom, B.E. Fee, G. Zambetti, J.L. Cleveland, and S.W. Hiebert. 1997. E2F-1 cooperates with topoisomerase II inhibition and DNA damage to selectively augment p53-independent apoptosis. Mol. Cell. Biol. 17: 1049-1056.
28. Quelle, F.W., D. Wang, T. Nosaka, W.E. Thierfelder, D. Stravopodis, Y. Weinstein, and J.N. Ihle. 1996. Erythropoietin induces activation of Stat5 through association with specific tyrosines on the receptor that are not required for a mitogenic response. Mol. Cell. Biol. 16: 1622-1631.
29. Ridley, A.J., P.M. Comoglio, and A. Hall. 1995. Regulation of scatter factor/hepatocyte growth factor responses by Ras, Rac, and Rho in MDCK cells. Mol. Cell. Biol. 15: 1110-1122.
30. Suva, M., D. Grillot, A. Benito, C. Richard, G. Nunez, and J.L. Fernandez-Luna. 1996. Erythropoietin can promote erythroid progenitor survival by repressing apoptosis through Bel-XL and Bcl-2. Blood 88: 1576-1582.
31. Tauchi, T., J.E. Damen, K. Toyama, G.S. Feng, H.E. Broxmeyer, and G. Krystal. 1996. Tyrosine 425 within the activated erythropoietin receptor binds Syp, reduces the erythropoietin required for Syp tyrosine phosphorylation, and promotes mitogenesis. Blood 87: 4495-4501.
32. Witthuhn, B.A., F.W. Quelle, O. Silvennoinen, T. Yi, B. Tang, O. Miura, and J.N. Ihle. 1993. JAK2 associates with the erythropoietin receptor and is tyrosine phosphorylated and activated following stimulation with erythropoietin. Cell 74: 227-236.
33. Yonish-Rouach, E., D. Grunwald, S. Wilder, A. Kimchi, E. May, J.J. Lawrence, P. May, and M. Oren. 1993. p53-mediated cell death: relationship to cell cycle control. Mol. Cell. Biol. 13: 1415-1423.
34. Zambetti, G.P. and A.J. Levine. 1993. A comparison of the biological activities of wild-type and mutant p53. FASEB J. 7: 855-865.
35. Zhuang, H., Z. Niu, T.C. He, S.V. Patel, and D.M. Wojchowski. 1995. Erythropoietin-dependent inhibition of apoptosis is supported by carboxyl-truncated receptor forms and blocked by dominant-negative forms of Jak2. J. Biol. Chem. 270: 14500-14504.